by Truveta Research | Nov 9, 2025 | Research, Research Insights
Authors: Katherine Brown, PhD, MSN, RN ⊕Truveta, Inc, Bellevue, WA, Sarah Platt, MS ⊕Truveta, Inc, Bellevue, WA, Agnes Pastwa ⊕Truveta, Inc, Bellevue, WA, Sunny Guin, PhD ⊕Truveta, Inc, Bellevue, WA, Emily Webber, PhD ⊕Truveta, Inc, Bellevue, WA Advanced natural...
by Truveta staff | Nov 5, 2025 | Research
Understanding the complete view of healthcare requires seeing both what care is delivered and why. Closed claims data show what care occurs, capturing procedures, pharmacy activity, amount paid, and services delivered beyond a single health system’s network....
by Truveta staff | Oct 29, 2025 | Research
Body composition is a critical factor in understanding health risk, yet it is rarely measured in routine clinical care. Instead, clinicians and researchers often rely on BMI — a measure that misses the nuance of fat distribution and its impact on outcomes like...
by Truveta Research | Oct 24, 2025 | Featured post, Research, Research Insights
Respiratory virus–associated hospitalizations declined overall in September 2025 (–27.1%). COVID-associated hospitalizations declined substantially (-45.1%) but still account for the most virus-associated hospitalizations in those aged 65 and older (1.1%). Rhinovirus...
by Truveta Research | Oct 21, 2025 | Research, Research Insights
In patients with CKD and diabetes, anemia prevalence and severity increased from stage 1 to stage 5, with overall anemia rising from 46.4% to 85.0% and severe anemia from 2.5% to 11.8% Erythropoiesis-stimulating agents (ESAs) and IV iron use rose as hemoglobin levels...
by Truveta Research | Oct 20, 2025 | Research, Research Insights
Overall GLP-1 prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%). As of September 2025, GLP-1 prescriptions account for 6.5 out of every 100 prescriptions in the US. Tirzepatide continues...
